Artiva Biotherapeutics, Inc.
ARTV · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 6, 2026 | — | — | — | -0.64 | — |
| 2026 Q1 | May 8, 2026 | — | — | -0.95 | -0.88 | — |
| 2025 Q4 | March 10, 2026 | — | — | -0.84 | -0.87 | — |
| 2025 Q3 | November 12, 2025 | — | — | -0.88 | -0.92 | +10.86% |
| 2025 Q2 | August 6, 2025 | — | — | -0.87 | -0.84 | — |
| 2025 Q1 | May 8, 2025 | — | — | -0.83 | -0.68 | — |
| 2024 Q4 | March 24, 2025 | — | — | -0.66 | -0.71 | -8.77% |
| 2024 Q3 | November 12, 2024 | — | — | -0.92 | -0.68 | — |
| 2024 Q2 | August 29, 2024 | 251.00K | — | -22.00 | -4.40 | — |